Kyung-Min Lee
9PUBLICATIONS
41CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (9)
Sort by Publication Date:
|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang
|Jul 28, 2023
Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang
|Feb 25, 2023
Special Issue: Resistance to Targeted Therapies in Human Cancer.Tae-Won Lee, Hee-Joo Choi, Kyung-Min Lee
|Oct 24, 2022
Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells.Seogho Son, Seung-Ah Yoo, KeeSoo Nam
|Jul 05, 2022
ECM1 is associated with endocrine resistance in ER+ breast cancers.Tae Won Lee, Kyung-Min Lee
Pageof 2
Frequent Collaborators
4 joint publications
Ariella B Hanker
4 joint publications
Carlos L Arteaga
2 joint publications
Paula I González Ericsson
2 joint publications
Lin Xu
2 joint publications
Chang-Ching Lin
2 joint publications
Joshua T Mendell
2 joint publications
David W Cescon
2 joint publications
Ram Mani
1 joint publications
Angel L Guerrero-Zotano
1 joint publications
Mun Seog Chang